Navigation Links
Rapid detection of genomic,,,duplications and deletions using,,,the Agilent 2100 bioanalyzer

Duplications and deletions are known to cause a wide variety of human diseases. Many different methods are used for detecting such rearrangements, most based on either FISH or the quantitative analysis of PCR products. FISH is popular and accurate, but very labour intensive and expensive, while quantitative PCR methods are technically demanding and difficult to design. Recently two related methods (MAPH and MLPA) have been developed and applied to different disorders. Several methods for the analysis of the products were used, using a labeled primer and either gel or capillary electrophoresis. This Application Note describes the Agilent 2100 bioanalyzer in combination with the DNA 500 chip for the detection of copy number changes within the genome using MAPH and MLPA. The speed, ease of data analysis and potential for automation make this an attractive alternative for conventional methods in a diagnostic setting.
Alterations in genomic DNA can be broadly divided into 3 main classes: (i) qualitative changes, where the DNA sequence is altered, (ii) changes of order e.g. translocations and inversions, and (iii) quantitative changes, involving the deletion or duplication of a stretch of DNA. Sequencing has long been the gold standard for qualitative changes, and fluorescent in situ hybridization (FISH) and pulsed-field gel electrophoresis (PFGE) are the most widely applied methods for detecting the reordering of genomic segments. Until recently, the 3 methods predominantly used for quantitative analysis were Southern blotting, quantitative or breakpoint-specific PCR, and FISH. Southern blotting is time-consuming and laborious, and it is especially difficult to detect duplications. Quantitative PCR allows the multiplexing of up to 15 products in a single reaction, but has proved technically difficult in practice. The fact that each primer pair has to be optimized when combined in a given PCR reaction limits the mix and match potential. FISH is a visual method, meaning that the number of signals seen corresponds to the copy number of the probe. The disadvantages are the time-consuming preprocessing necessary before the analysis can be performed and the relatively low resolution (approx. 40 kb for a cosmid probe). Although this is more than adequate for larger rearrangements, small (e.g. single exon) deletions and duplications are not usually detected with this method. Two high resolution, high throughput techniques have recently been described for quantitative analysis of DNA, namely multiplex amplifiable probe hybridization (MAPH)1 and multiplex ligation-dependent probe amplification (MLPA)2. Both are based on quantitative amplification using a single pair of primers following probe hybridization to genomic DNA. The difference lies in the probes and the way the genomic DNA is handled. MAPH probes are PCR products that are hybridized to genomic DNA immobilized onto a nylon membrane. After hybridization the unbound probes are removed by stringent washing, with the bound probes being subsequently denatured and amplified in a PCR reaction. As the probes are designed to all have identical sequences at each end, the PCR reaction can be performed with a single primer pair. MLPA is a ligation-based assay, with 2 single stranded DNA sequences being ligated together only if they both hybridize adjacently to their complementary sequences on genomic DNA. As unligated probes can not be PCR amplified it is not necessary to immobilize the genomic DNA (in contrast to MAPH), and the washing steps can also be skipped.
Different methods for the analysis and the quantitation of the PCR products have been described. The DNA is labeled with either radioactive or fluorescent molecules during the PCR step, and the separation has been performed by electrophoresis, either on a polyacrylamide gel or capillary system. We have tried the possibility of analyzing the MLPA and MAPH products using the Agilent 2100 bioanalyzer in combination with the DNA 500 chip. Parameters under investigation included resolution, reproducibility and the accuracy of quantitation.
Methods
MAPH
A total of 17 female DNA samples were examined, of whom 13 were known to be carriers for mutations in the DMD gene and 4 were non-carriers. The MAPH protocol has been described previously3, and is also available on http://www.dmd.nl/DMD_MAPH.html For each hybridization several DMD gene exon probes were chosen, both within and outside the suspected breakpoints. At least 2 control autosomal probes were also included in the probe mix.
MLPA
Full details regarding the MLPA protocol are in reference 2, and on the website http://www.mrc-holland.nl/ The MLPA reaction was performed on male and female DNA, as well as DNA from a cell line 49,XXXXY. Bioanalyzer analysis was performed according to the manufacturer's instructions. The peak patterns were visually compared using the Bio Sizing Data Evaluation program (Agilent Technologies).
Results and discussion

We have previously published work on the analysis of deletions and duplications in the DMD geneusing MAPH3. While this concentrated on the analysis of a large group of samples, it is often necessary or sufficient to screen only one or a small number of samples with a few probes. This is particularly the case when a relative of a patient wishes to be screened for carrier status. In this case the mutation to look for is already known, and the question is simply whether a given DNA sample has the same mutation. It is therefore not necessary to examine all 79 exons, but simply compare probes for exons within the potential rearrangement to those outside. To test whether the Agilent system would be suitable for this analysis we first had to determine the practical resolution of separation and the minimum concentration required for accurate analysis. An experiment was performed to separate fragments of a known length. It was found that having a probe separation of > 20 base pairs resulted in peaks that could readily be distinguished (figure 1). We routinely amplify the MAPH products with a 25 cycle PCR reaction. This gave sufficient product to be easily detected. A concentration of approximately 0.5 ng/l is necessary to give a peak of approximately 5 units in height, the default minimum set in the analysis program. We analyzed a total of 17 samples from females where the carrier status was known4. For each sample at least 1 exon was chosen within the deleted/duplicated region, and several exons outside. Changes in peak height correspond to changes in copy number, and in most cases the difference could be easily detected by eye (figure 2).

Exon specific peaks were all normalized against unlinked autosomal probes, and the normalized ratios of the exons within the rearrangement were compared with those from exons outside the rearrangement using Student's ttest (table 1).

In the 13 cases where the female was a carrier the differences were highly significant (p < 0.001), whereas the 4 non-carriers showed no significant difference (p > 0.1). To estimate the error rate of the assay the 99 % confidence intervals of the difference were calculated. The ranges are such that the actual error rate is likely to be lower than the predicted rate of 1 %. It should also be possible to detect mosaic cases i.e. when the mutation is not present in all of the cells and is therefore masked by the presence of normal cells. In these cases the p-value may fall into the retest range. In such cases alternative methods such as FISH could be employed to confirm this.
We also looked at testing MLPA reactions on the DNA 500 chip. Initial tests were performed with a test kit provided by MRC Holland (Nederland). The resulting peaks can be analyzed in exactly the same way as those obtained from a MAPH experiment. An example of the results can be seen in figure 3. The difference in the number of X chromosomes can be easily seen as differences in peak height of the appropriate probes. In this regard the software provided (BioSizing Data Evaluation) makes it very easy to overlay different traces and make direct visual comparisons.
Conclusion
These experiments show that the Lab-on-a-chip combined with MAPH /MLPA is a quick and simple way to detect copy number changes in genomic DNA. Particular strengths are the speed and relative automation of analysis. The resolution is sufficient to separate up to 15 probes accurately on the DNA 500 chip, more than sufficient when examining only one particular area of the genome. We consider this technique to be an attractive alternative to FISH in a diagnostic setting, particularly for mutations that cannot be readily detected in such a manner.



'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
2. A Simple and Rapid Technique to Purify High-Quality Midiprep DNA
3. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
4. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
5. HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex Virus DNA
6. Simple and Rapid Isolation of Plant RNA Using the Eppendorf Perfect RNA, Eukaryotic, Maxi Kit
7. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
8. Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation
9. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
10. Rapidly Prepare Probes and Markers for Small RNA Analysis
11. Rapidly Synthesize Large Amounts of Capped RNA

Post Your Comments:
(Date:11/24/2009)...NTA CRUZ, Calif., Nov. 24 Two more...enter, the nation,s leading online job board and c...Northwestern and Columbia University are now membe...cience training Institutions. ,, The job board,...ates in the life sciences. While there are hundred...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PRNews...DCGN ) today announced that it has received notice...company,s common stock will be,suspended as of Nov...h the,Securities and Exchange Commission, which wi...sdaq, unless the company files an appeal to the Na...
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharma...mark Office (PTO) has allowed the patent applicati...nology. , NOD technology is a highly effi... into bio-adhesive nano-particles to enable oral d...ons. NOD technology is a platform technology,that ...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...chem Laboratories, Inc., a leading research-based ...Drug Products to the pharmaceutical industry, with...ce the recent addition of Dr. Chris Huber as Direc...s to the table over 15 years experience in the pha...oping process technology for API manufacturing of ...
...Biosciences Corporation (Nasdaq: MATK ) announce...cond quarter of fiscal 2009 on June 3, 2009, at ap...g the release, at 4:45 p.m. ET Martek will conduct...nvestors. All interested parties may listen to th...ite at http://investors.martek.com . , , An ...
...ault Corporation is pleased to announce notice of ...folio. U.S. Patent Application #10/005,415, entit...age, Retrieval & Analysis of a Large Number of...78.6, entitled " Archive & Analysis System and...ent U.S. Patent #7,142,987. Taken together, these...
Other Biology Technology:Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development 2GenVault Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies 2
(Date:11/24/2009)...al Toxicology (ACMT) have signed an agreement to c...edical Toxicology (JMT), the official journal of ...sly published by the University of Pennsylvania Pr...international, peer-reviewed journal, is dedicated...toxicology. The quarterly journal focuses on the ...
(Date:11/24/2009)...crets of the earth,s history locked in its icy dep...e information on the environments that have been s...Now, a team of researchers from nine institutions ...0 million dollars by the National Science Foundati...lly. These scientists will drill through the West ...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Depression May Lead to More Preemies Among Blacks 49006 1Depression May Lead to More Preemies Among Blacks 49006 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 1Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 3Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once Daily INFERGEN 28R 29 with Ribavirin in Hepatitis C Virus Treatment Failures 12641 1Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once Daily INFERGEN 28R 29 with Ribavirin in Hepatitis C Virus Treatment Failures 12641 2Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once Daily INFERGEN 28R 29 with Ribavirin in Hepatitis C Virus Treatment Failures 12641 3Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once Daily INFERGEN 28R 29 with Ribavirin in Hepatitis C Virus Treatment Failures 12641 4
... (DECEMBER 26, 2008) A team of scientists from th...S) has reported a rapid recovery of coral reefs in...vastated coastal regions throughout the Indian Oce...am, working in conjunction with the Australian Res...Studies (ARCCoERS) along with government, communit...
... organic crop production is increasing around the ...ding environmental benefits and decreasing the amo...ter. While organics gain popularity with consumers...allenges, especially managing and reducing invasiv...etroleum-based materials, have been used extensive...
...mployers in the landscape industry revealed the im...udents with technical knowledge, practical applica...s the skills necessary to solve complex landscape ...ccess. , With the rapid advancement of technology...e to present students with virtual case studies vi...
Other Biology News:4 years after tsunami: Corals stage comeback 24 years after tsunami: Corals stage comeback 3Organic plant waste proves effective weed control for citrus trees 2Organic plant waste proves effective weed control for citrus trees 3Web-based case studies help students develop career skills 2
Methadone ELISA Kit, Single from Bio-Quant Inc.
Rat Prolactin EIA Kit from Cayman Chemical
Z Amphetamine ELISA Kit, Single from Bio-Quant Inc.
Mumps IgG ELISA Kit, Single from Bio-Quant Inc.
Biology Products: